Page 108 - 《中国药房》2024年12期
P. 108

参考文献                                                     174-178.
          [ 1 ]  FARHADI J,NOURI M,SAKHINIA E,et al. Epigenetics   CHEN L,WU B H,YAN K. Disproportional method ap-
               and  Behçet’s  disease:DNA  methylation  specially  high‐  plied  in  ADR  signal  mining  of  bevacizumab[J].  Cent
               lighted[J]. Iran J Allergy Asthma Immunol,2019,18(5):  South Pharm,2018,16(2):174-178.
               462-472.                                       [ 9 ]  ZHOU Y,CHEN M Y,LIU L B,et al. Difference in gas‐
          [ 2 ] 卓楠,周真宝.糖皮质激素治疗葡萄膜炎的疗效分析[J].                        trointestinal  risk  associated  with  use  of  GLP-1  receptor
               慢性病学杂志,2021,22(3):395-396.                          agonists:a real-world pharmacovigilance study[J]. Diabe‐
               ZHUO N,ZHOU Z B. Analysis of the curative efficacy of   tes Metab Syndr Obes,2022,15:155-163.
                                                              [10]  张丹丹,张宁,孙河,等 . 基于六经八纲辨证体系分析
               glucocorticoid  in  the  treatment  of  uveitis[J].  Chronic  Pa-
                                                                   272例葡萄膜炎患者相关因素及证候特征[J]. 中国中医
               thematol J,2021,22(3):395-396.
                                                                   眼科杂志,2023,33(8):721-726.
          [ 3 ]  王蒙蒙,任戎,李丽,等 . 糖皮质激素在重型及危重型
                                                                   ZHANG  D  D,ZHANG  N,SUN  H,et  al.  Analysis  of
               COVID-19 患者中的应用进展[J]. 中南药学,2022,20
                                                                   related  factors  and  syndrome  characteristics  in  272
              (7):1605-1609.
                                                                   patients  with  uveitis  based  on  six-channel  and  eight-
               WANG M M,REN R,LI L,et al. Application of glucocor‐
                                                                   principle  pattern  identification[J].  China  J  Chin  Ophthal‐
               ticoids in severe and critical COVID-19 patients[J]. Cent
                                                                   mol,2023,33(8):721-726.
               South Pharm,2022,20(7):1605-1609.
                                                              [11]  张琛,高炳爱,陈玉欣,等. 结节性红斑的病因及发病机
          [ 4 ]  U.S. Food and Drug Administration.Drug approval package:
                                                                   制[J]. 中国麻风皮肤病杂志,2015,31(7):408-410.
               Yutiq[EB/OL].(2019-02-07)[2023-11-13]. https://www.
                                                                   ZHANG  C,GAO  B  A,CHEN  Y  X,et  al.  Causes  and
               accessdata. fda. gov/drugsatfda_docs/nda/2018/210331Orig-
                                                                   pathogenesis of erythema nodosum[J]. China J Lepr Skin
               1s000Lbl.pdf.
                                                                   Dis,2015,31(7):408-410.
          [ 5 ]  STEEPLES L R,POCKAR S,JONES N P,et al. Evalua-
                                                              [12]  JAFFE G J,MARTIN D,CALLANAN D,et al. Fluocino‐
               ting the safety,efficacy and patient acceptability of intra‐
                                                                   lone  acetonide  implant(Retisert)for  noninfectious  poste‐
               vitreal  fluocinolone  acetonide(0.2  mcg/day)  implant  in
                                                                   rior uveitis:thirty-four-week results of a multicenter ran‐
               the treatment of non-infectious uveitis affecting the poste‐
                                                                   domized clinical study[J]. Ophthalmology,2006,113(6):
               rior segment[J]. Clin Ophthalmol,2021,15:1433-1442.
                                                                   1020-1027.
          [ 6 ]  LY T,PAMER C,DANG O,et al. Evaluation of natural
                                                              [13]  BISWAS J,TYAGI M,AGARWAL M,et al. The 0.2 μg/
               language  processing(NLP)systems  to  annotate  drug
                                                                   day fluocinolone acetonide intravitreal implant in chronic
               product labeling with MedDRA terminology[J]. J Biomed
                                                                   noninfectious  posterior  uveitis:a  3-year  randomized  trial
               Inform,2018,83:73-86.                               in India[J]. Ophthalmol Sci,2023,4(1):100403.
          [ 7 ]  夏兰芳,李燕,李克莉,等. 药品不良反应比例失衡分析
                                                              [14]  夏旭东,柳鹏程,周明,等. 基于H 省药品不良反应真实
               方法信号检测中扬名偏倚及其影响[J]. 中国疫苗和免                          世界数据对信号检测方法的比较研究[J]. 中国食品药品
               疫,2022,28(6):730-735.                               监管,2023(10):42-55.
               XIA L F,LI Y,LI K L,et al. Notoriety bias and its impact   XIA X D,LIU P C,ZHOU M,et al. Comparative study on
               on signal detection of adverse drug reactions using dispro‐  signal detection methods based on real world data of ad‐
               portionality analysis:a literature review[J]. Chin J Vaccines   verse  drug  reactions  in  H  province[J].  China  Food  Drug
               Immun,2022,28(6):730-735.                           Adm Mag,2023(10):42-55.
          [ 8 ]  陈力,吴邦华,闫康. 比例失衡法在贝伐珠单抗药品不良                                 (收稿日期:2023-12-22  修回日期:2024-02-19)
               反应信号挖掘中的应用[J]. 中南药学,2018,16(2):                                                    (编辑:舒安琴)
















          · 1510 ·    China Pharmacy  2024 Vol. 35  No. 12                            中国药房  2024年第35卷第12期
   103   104   105   106   107   108   109   110   111   112   113